reviewNature Reviews Drug DiscoveryFeb 17, 2022GREEN OA

The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

EKEric Karran BDBart De Strooper

AbbVie (United States) · UK Dementia Research Institute · +2 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

683

total citations

FWCI: 75.34
Percentile: 100%
References: 146

Citations per year

Authors

2

EK
Eric KarranCorresponding
AbbVie (United States)
BD
Bart De Strooper
UK Dementia Research Institute, VIB-KU Leuven Center for Brain & Disease Research, University College London

Topics & keywords

Topics

Keywords

Clinical trial
Medicine
Amyloid (mycology)
Context (archaeology)
Disease
Alzheimer's disease
Pathognomonic
Surrogate endpoint

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.